Trust Size
$448M
What Happened
BridgeBio Oncology Therapeutics, Inc. (HLXB) filed its S-1 registration in 2024. The company remains actively traded with 131 SEC filings on record.
BridgeBio Oncology Therapeutics, Inc. entered the SPAC market in 2024 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
SEC records show 131 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company was incorporated in Delaware, the preferred jurisdiction for the vast majority of SPACs due to its business-friendly legal framework.
Timeline
2024-02-07
S-1 Registration Filed
SEC Filing Details
CIK Number
1869105
Total SEC Filings
131
State of Incorporation
DE
Last Filing Date
2026-03-12
Business Location
Boston, MA
Trust/Asset Size
$448M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
ð SEC Filings
View all EDGAR filings for BridgeBio Oncology Therapeutics